CPT® Code 83071

Deleted

1. Indications

The quantitative test for hemosiderin, as indicated by CPT® Code 83071, is performed under specific clinical circumstances. The primary indications for this procedure include:

• Intravascular Hemorrhage The presence of hemosiderin in urine serves as a marker for intravascular hemorrhage, which may occur due to various medical conditions or injuries.
• Monitoring Hemolytic Conditions This test may be indicated in patients with hemolytic anemia or other conditions that lead to the breakdown of red blood cells, resulting in elevated free hemoglobin levels.
• Assessment of Kidney Function The test can help evaluate the kidney's ability to excrete hemosiderin, providing insights into renal function and potential damage.

2. Procedure

The procedure for conducting a quantitative hemosiderin test involves several key steps, which are outlined as follows:

• Step 1: Sample Collection A random urine sample or a first morning voided specimen is collected from the patient. The timing of the sample collection is crucial, as the first morning void is often more concentrated and may provide more accurate results.
• Step 2: Laboratory Analysis The collected urine sample is then sent to a laboratory where it undergoes quantitative analysis. This involves using specific methodologies to measure the concentration of hemosiderin present in the urine.
• Step 3: Interpretation of Results Once the analysis is complete, the results are interpreted by a qualified healthcare professional. The quantitative measurement of hemosiderin is compared against established reference ranges to determine if the levels are within normal limits or indicative of a pathological condition.

3. Post-Procedure

After the hemosiderin quantitative test is performed, there are generally no specific post-procedure care requirements for the patient, as the test involves non-invasive urine collection. However, it is essential for healthcare providers to communicate the results to the patient and discuss any necessary follow-up actions based on the findings. If elevated levels of hemosiderin are detected, further diagnostic evaluations or treatments may be warranted to address the underlying cause of the intravascular hemorrhage or related conditions.